CD8A and neoplasm: Enhanced numbers of GzmB producing CD4+ and CD8+ T cells in tumor patients after combination treatment with antibodies against PD-1 and CTLA-4 have previously been described [73], but this study did not perform a detailed characterization of the GzmB producing cells.